Revumenib(Revuforj)

Another NameLuciRevu、revumenib,瑞维美尼

IndicationsIndicated for adults and pediatric patients ≥1 year with relapsed/refractory KMT2A-translocated acute leukemia or NPM1-mutated AML without other suitable treatments.